N/A
N=713
Development and Validation of a Daily Pain Catastrophizing Scale
Chronic Pain
Bottom Line
View on ClinicalTrials.gov: NCT02778555 ↗Enrolled (actual)
713
Serious AEs
0.0%
Results posted
Jun 2019
Primary outcome: Primary: Factor Analysis & PROMIS Correlation for Samples 2 & 3 — NA; .990; NA; NA Pearson Coefficients
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Questionnaires (Behavioral)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Stanford University
- Primary completion
- Mar 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Factor Analysis & PROMIS Correlation for Samples 2 & 3 |
NA; .990; NA; NA; .581; .528 | — |
Summary
This study sought to develop and validate a brief, daily version of the Pain Catastrophizing Scale.
Eligibility Criteria
Inclusion Criteria
- Age 18 or above
- Chronic pain of any etiology
- Online access
- Ability to participate in daily measurements over 14 days
Exclusion Criteria
- Lack of ability to answer questionnaires and daily catastrophizing captures, at the discretion of study staff.
Data sourced from ClinicalTrials.gov (NCT02778555). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.